FIELD: medicine, neurology, psychiatry.
SUBSTANCE: the innovation deals with anti-convulsive therapy along with electroencephalographic monitoring. Moreover, 3 mo after achieving clinico-electroencephalographic remission of epileptic process it is important to prescribe therapy with acanthinol memantine at the dosage of 250 mcg/kg/d and starting since the 2nd wk - 500 mcg/kg/d, in the morning, after meals. The course with acanthinol memantine lasts for 2 mo. The innovation provides improved cognitive functions, sound pronunciation, decreased number of tempo disorders of speech in children due to complex modeling effect of acanthinol memantine upon glutamatergic system, normalization of membranous potential and improved process of transmission of nervous impulses.
EFFECT: higher efficiency of therapy.
2 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING THE SEVERITY OF JUVENILE MYOCLONUS EPILEPSY IN CHILDREN | 2006 |
|
RU2310377C1 |
| METHOD FOR PREDICTING AND TREATING IDIOPATHIC GENERALIZED EPILEPSY IN CHILDREN | 2005 |
|
RU2297176C2 |
| METHOD OF CHILDREN ABSENTIA TREATMENT ASSOCIATED WITH IDIOPATHIC GENERALISED EPILEPSY | 2005 |
|
RU2329761C2 |
| METHOD FOR PREDICTING MENTAL DISORDERS DEVELOPMENT IN SECONDARY BILATERAL SYNCHRONIZATION PHENOMENON BEING FORMED IN CHILDREN SUFFERING FROM EPILEPSY WITH TEMPORAL AND FRONTAL LOCALIZATION OF PRIMARY EPILEPSY FOCUS | 2005 |
|
RU2314749C2 |
| METHOD OF TREATING APHASIAS | 2007 |
|
RU2380111C2 |
| METHOD FOR COMPLEX THERAPY OF EPILEPSY IN TEENAGERS | 2002 |
|
RU2238035C2 |
| METHOD OF ESTIMATING SEVERITY DEGREE OF EPILEPSY COMPLICATED BY ORGANIC ENCELOPHATHY | 2009 |
|
RU2433784C2 |
| METHOD FOR EVALUATING EPILEPSY PHARMACOTHERAPY EFFECTIVENESS | 2000 |
|
RU2164688C1 |
| TREATMENT USING ESLICARBAZEPINE ACETATE OR ESLICARBAZEPINE | 2012 |
|
RU2639120C2 |
| USE OF CARBAMATE DERIVATIVE FOR PREVENTION, RELIEF, OR TREATMENT OF MINOR EPILEPTIC SEIZURE OR EPILEPSY SHOWING MINOR EPILEPTIC SEIZURE | 2018 |
|
RU2787771C2 |
